Vanda Pharmaceuticals And Novartis Settle License Dispute By: Benzinga via Benzinga December 23, 2014 at 08:08 AM EST Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) announced on Monday that it has agreed to settle a dispute over the rights to Fanapt with ... Read More >> Related Stocks: Novartis Ag ADR Vanda Pharmaceuticals